Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in Intensive Care Patients With Acute Kidney Injury
NCT01720030Phase 3Completed
- Sponsor
- VieCuri Medisch Centrum
- Start
- Sep 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levosimendan in acute kidney injury (AKI), sponsored by VieCuri Medisch Centrum. Started Sep 2016; status: completed.
02
Drugs
levosimendan
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT01720030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01720030.